Insider · CIK 0001903997
Arun Das
Files at CABA (Cabaletta Bio, Inc.). First filing -, latest -.
In brief
Arun Das files SEC Form 4 as officer at CABA (Cabaletta Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Arun Das has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | CABA Cabaletta Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Mar 2, 2026 |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,416 | $0.00 | $0 | 0 | May 19, 2025 |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +18,416 | $0.00 | $0 | 18,416 | May 19, 2025 |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | May 19, 2025 |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +35,000 | $0.00 | $0 | 35,000 | May 19, 2025 |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -100,000 | $0.00 | $0 | 0 | May 19, 2025 |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | May 19, 2025 |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -150,000 | $0.00 | $0 | 0 | May 19, 2025 |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +150,000 | $0.00 | $0 | 150,000 | May 19, 2025 |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -100,000 | $0.00 | $0 | 0 | May 19, 2025 |
| May 19, 2025 | CABA Cabaletta Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | May 19, 2025 |
| Mar 3, 2025 | CABA Cabaletta Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +115,000 | $0.00 | $0 | 115,000 | Mar 4, 2025 |
| Mar 1, 2024 | CABA Cabaletta Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Mar 4, 2024 |
Questions about Arun Das
Answered from the filings on this page, as of the latest one.
Is Arun Das buying or selling?
Arun Das has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Arun Das's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Arun Das has 0.
Where does Arun Das file Form 4?
Arun Das has filed Form 4 at CABA (Cabaletta Bio, Inc.) as Chief Business Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.